1. Home
  2. OCUL vs ALEX Comparison

OCUL vs ALEX Comparison

Compare OCUL & ALEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • ALEX
  • Stock Information
  • Founded
  • OCUL 2006
  • ALEX 1870
  • Country
  • OCUL United States
  • ALEX United States
  • Employees
  • OCUL N/A
  • ALEX N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • ALEX Real Estate Investment Trusts
  • Sector
  • OCUL Health Care
  • ALEX Real Estate
  • Exchange
  • OCUL Nasdaq
  • ALEX Nasdaq
  • Market Cap
  • OCUL 1.2B
  • ALEX 1.3B
  • IPO Year
  • OCUL 2014
  • ALEX N/A
  • Fundamental
  • Price
  • OCUL $7.00
  • ALEX $17.61
  • Analyst Decision
  • OCUL Strong Buy
  • ALEX Buy
  • Analyst Count
  • OCUL 7
  • ALEX 3
  • Target Price
  • OCUL $16.71
  • ALEX $22.50
  • AVG Volume (30 Days)
  • OCUL 917.6K
  • ALEX 240.7K
  • Earning Date
  • OCUL 03-10-2025
  • ALEX 02-27-2025
  • Dividend Yield
  • OCUL N/A
  • ALEX 5.11%
  • EPS Growth
  • OCUL N/A
  • ALEX N/A
  • EPS
  • OCUL N/A
  • ALEX 0.61
  • Revenue
  • OCUL $61,442,000.00
  • ALEX $230,949,000.00
  • Revenue This Year
  • OCUL $11.40
  • ALEX N/A
  • Revenue Next Year
  • OCUL $13.58
  • ALEX N/A
  • P/E Ratio
  • OCUL N/A
  • ALEX $21.50
  • Revenue Growth
  • OCUL 6.45
  • ALEX 1.30
  • 52 Week Low
  • OCUL $4.06
  • ALEX $15.53
  • 52 Week High
  • OCUL $11.78
  • ALEX $20.30
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 31.92
  • ALEX 43.41
  • Support Level
  • OCUL $7.14
  • ALEX $17.48
  • Resistance Level
  • OCUL $7.42
  • ALEX $18.09
  • Average True Range (ATR)
  • OCUL 0.37
  • ALEX 0.24
  • MACD
  • OCUL -0.02
  • ALEX -0.02
  • Stochastic Oscillator
  • OCUL 0.76
  • ALEX 21.31

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About ALEX Alexander & Baldwin Inc. REIT Holding Company

Alexander & Baldwin Inc operates in the real estate sector. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces and also urban ground leases in Hawaii, thereby accounting for majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.

Share on Social Networks: